vs
NAPCO SECURITY TECHNOLOGIES, INC（NSSC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是NAPCO SECURITY TECHNOLOGIES, INC的1.4倍（$69.8M vs $48.2M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 28.0%，领先356.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 12.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -1.1%）
纳普科安全技术公司1969年成立，总部位于纽约阿米蒂维尔，核心业务为研发生产各类安全产品，包括电子锁具、安防警报系统以及楼宇出入管控系统，曾用名纳普科安全系统公司。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NSSC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.4倍
$48.2M
营收增速更快
RIGL
高出9.0%
12.2%
净利率更高
RIGL
高出356.0%
28.0%
两年增速更快
RIGL
近两年复合增速
-1.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.2M | $69.8M |
| 净利润 | $13.5M | $268.1M |
| 毛利率 | 58.6% | 91.5% |
| 营业利润率 | 30.6% | 33.2% |
| 净利率 | 28.0% | 384.0% |
| 营收同比 | 12.2% | 21.2% |
| 净利润同比 | 29.0% | 1769.2% |
| 每股收益（稀释后） | $0.38 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NSSCRIGL
| Q4 25 | $48.2M | $69.8M | ||
| Q3 25 | $49.2M | $69.5M | ||
| Q2 25 | $50.7M | $101.7M | ||
| Q1 25 | $44.0M | $53.3M | ||
| Q4 24 | $42.9M | $57.6M | ||
| Q3 24 | $44.0M | $55.3M | ||
| Q2 24 | $50.3M | $36.8M | ||
| Q1 24 | $49.3M | $29.5M |
净利润NSSCRIGL
| Q4 25 | $13.5M | $268.1M | ||
| Q3 25 | $12.2M | $27.9M | ||
| Q2 25 | $11.6M | $59.6M | ||
| Q1 25 | $10.1M | $11.4M | ||
| Q4 24 | $10.5M | $14.3M | ||
| Q3 24 | $11.2M | $12.4M | ||
| Q2 24 | $13.5M | $-1.0M | ||
| Q1 24 | $13.2M | $-8.2M |
毛利率NSSCRIGL
| Q4 25 | 58.6% | 91.5% | ||
| Q3 25 | 56.6% | 93.2% | ||
| Q2 25 | 52.8% | 95.6% | ||
| Q1 25 | 57.2% | 91.7% | ||
| Q4 24 | 57.0% | 89.9% | ||
| Q3 24 | 55.9% | 85.5% | ||
| Q2 24 | 55.3% | 92.4% | ||
| Q1 24 | 53.8% | 93.1% |
营业利润率NSSCRIGL
| Q4 25 | 30.6% | 33.2% | ||
| Q3 25 | 27.7% | 40.9% | ||
| Q2 25 | 23.8% | 60.1% | ||
| Q1 25 | 25.4% | 23.9% | ||
| Q4 24 | 26.0% | 28.9% | ||
| Q3 24 | 26.9% | 25.4% | ||
| Q2 24 | 27.7% | 1.2% | ||
| Q1 24 | 29.4% | -23.6% |
净利率NSSCRIGL
| Q4 25 | 28.0% | 384.0% | ||
| Q3 25 | 24.7% | 40.2% | ||
| Q2 25 | 22.9% | 58.6% | ||
| Q1 25 | 23.0% | 21.5% | ||
| Q4 24 | 24.4% | 24.9% | ||
| Q3 24 | 25.4% | 22.5% | ||
| Q2 24 | 26.9% | -2.8% | ||
| Q1 24 | 26.8% | -27.9% |
每股收益（稀释后）NSSCRIGL
| Q4 25 | $0.38 | $14.11 | ||
| Q3 25 | $0.34 | $1.46 | ||
| Q2 25 | $0.33 | $3.28 | ||
| Q1 25 | $0.28 | $0.63 | ||
| Q4 24 | $0.28 | $0.82 | ||
| Q3 24 | $0.30 | $0.70 | ||
| Q2 24 | $0.36 | $-0.06 | ||
| Q1 24 | $0.36 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.4M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $184.8M | $391.5M |
| 总资产 | $212.8M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NSSCRIGL
| Q4 25 | $115.4M | $155.0M | ||
| Q3 25 | $105.8M | $137.1M | ||
| Q2 25 | $99.2M | $108.4M | ||
| Q1 25 | $89.3M | $77.1M | ||
| Q4 24 | $99.2M | $77.3M | ||
| Q3 24 | $91.3M | $61.1M | ||
| Q2 24 | $70.7M | $49.1M | ||
| Q1 24 | $60.9M | $49.5M |
总债务NSSCRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益NSSCRIGL
| Q4 25 | $184.8M | $391.5M | ||
| Q3 25 | $176.1M | $117.6M | ||
| Q2 25 | $168.6M | $81.9M | ||
| Q1 25 | $161.5M | $18.6M | ||
| Q4 24 | $174.2M | $3.3M | ||
| Q3 24 | $178.6M | $-14.6M | ||
| Q2 24 | $178.9M | $-29.9M | ||
| Q1 24 | $168.2M | $-31.7M |
总资产NSSCRIGL
| Q4 25 | $212.8M | $513.6M | ||
| Q3 25 | $206.0M | $242.5M | ||
| Q2 25 | $198.1M | $206.7M | ||
| Q1 25 | $190.9M | $176.0M | ||
| Q4 24 | $202.7M | $164.0M | ||
| Q3 24 | $209.9M | $139.4M | ||
| Q2 24 | $207.8M | $128.4M | ||
| Q1 24 | $194.8M | $126.5M |
负债/权益比NSSCRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $14.5M | — |
| 自由现金流率自由现金流/营收 | 30.1% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | 1.12× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $53.7M | — |
8季度趋势，按日历期对齐
经营现金流NSSCRIGL
| Q4 25 | $15.1M | $22.0M | ||
| Q3 25 | $11.6M | $24.0M | ||
| Q2 25 | $14.6M | $30.5M | ||
| Q1 25 | $13.4M | $-893.0K | ||
| Q4 24 | $13.5M | $14.5M | ||
| Q3 24 | $12.0M | $21.7M | ||
| Q2 24 | $14.3M | $302.0K | ||
| Q1 24 | $12.3M | $-5.0M |
自由现金流NSSCRIGL
| Q4 25 | $14.5M | — | ||
| Q3 25 | $11.4M | — | ||
| Q2 25 | $14.4M | — | ||
| Q1 25 | $13.3M | — | ||
| Q4 24 | $12.4M | — | ||
| Q3 24 | $11.3M | — | ||
| Q2 24 | $13.8M | — | ||
| Q1 24 | $12.0M | — |
自由现金流率NSSCRIGL
| Q4 25 | 30.1% | — | ||
| Q3 25 | 23.3% | — | ||
| Q2 25 | 28.4% | — | ||
| Q1 25 | 30.3% | — | ||
| Q4 24 | 28.8% | — | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 27.4% | — | ||
| Q1 24 | 24.3% | — |
资本支出强度NSSCRIGL
| Q4 25 | 1.2% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 0.7% | — |
现金转化率NSSCRIGL
| Q4 25 | 1.12× | 0.08× | ||
| Q3 25 | 0.96× | 0.86× | ||
| Q2 25 | 1.26× | 0.51× | ||
| Q1 25 | 1.32× | -0.08× | ||
| Q4 24 | 1.29× | 1.01× | ||
| Q3 24 | 1.08× | 1.75× | ||
| Q2 24 | 1.06× | — | ||
| Q1 24 | 0.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
